DREAMM-10
Phase 3 Clinical Trial Comparing the Safety and Efficacy of Belantamab Mafodotin, Lenalidomide and Dexamethasone Versus Daratumumab, Lenalidomide and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma who are Ineligible for Autologous Stem Cell Transplant
Near Add Your Location
Sorting 28 by
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack Meridian Health
Hackensack, NJ
- Accepting patients
Mayo Clinic (Arizona)
Phoenix, AZ
- Accepting patients
- Accepting patients
Ohio State University Comprehensive Cancer Center
James Cancer Hospital and Solove Research Institute
Columbus, OH
- Accepting patients
University of Texas at Austin
Austin, TX
- Accepting patients
Stony Brook University Hospital
Stony Brook, NY
- Accepting patients
- Accepting patients
- Accepting patients
Weill Cornell
New York, NY
- Accepting patients
University of Massachusetts Medical School
Worcester, MA
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.